about
Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancerOvarian cancer biomarker discovery based on genomic approachesMunicipal distribution of ovarian cancer mortality in Spain.Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancerRisk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population.Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistryRisk factors for ovarian cancer: an overview with emphasis on hormonal factors.A Single Nucleotide Polymorphism in Catalase Is Strongly Associated with Ovarian Cancer SurvivalRole of BRCA1 and BRCA2 mutations in pancreatic cancer.Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study.Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series.Do hereditary syndrome-related gynecologic cancers have any specific features?Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system.Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria: identification of a BRCA1 ovarian cancer phenotype.Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer.Opportunistic salpingectomy for ovarian cancer preventionRecent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.Ovarian cancer stroma: pathophysiology and the roles in cancer development.High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population.Future directions in the management of epithelial ovarian cancer.Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilizationNovel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway.Epidemiology of ovarian cancer: a review.BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications.Hereditary gynaecological malignancies: advances in screening and treatment.Pancreatic cancer: BRCA mutation and personalized treatment.Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer.Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.BRCA mutations in the manifestation and treatment of ovarian cancer.Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin.A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer.Two patients with germline mutations in both BRCA1 and BRCA2 discovered unintentionally: a case series and discussion of BRCA testing modalities
P2860
Q26777453-D93B4896-5DA8-40C2-AC6C-5E551F067E76Q27013687-E1F559C1-3769-4637-99D5-6EFD7D7F9F19Q33369216-0D434F8C-0F6E-4EF7-92C9-B519D0D0194AQ33704050-5B6CBE9A-693F-4FE8-AA0C-12BF3A962368Q33723561-FAC5D771-A68F-410F-9F18-CD1ECDC07E03Q33741652-7683141F-3AA8-4712-B730-8B4CB5E3FF39Q33829394-C5711B8D-B263-45EA-8A63-A2BB9CEB56CAQ34442933-9ECC2D81-F01C-4365-9472-10ECD8114BC5Q34764768-E8B43C17-D971-4E11-9AE0-2BBF39A1F771Q35753523-A296C0CB-DA48-41A6-8106-EEA2C6A4EE21Q35929538-F0153D04-6C02-49B2-A2C7-A80A5CB2CC9DQ35994562-9CE1CDAA-73E7-44D5-BCE0-F37F968F705AQ36031290-86D2DA35-9AB9-4047-ABD7-7E05C4EF31DCQ36039893-7EA5009A-31EB-41DA-BCED-2BA785B598FBQ36059087-D4133CD1-C450-4116-99DE-C3F30A6E3876Q36108520-AB00A38B-48C3-45A7-A20A-1C042231ED9CQ36130577-7CCBA247-7F29-437A-87B6-19C8505F8412Q36173170-9CDE9429-9C2A-4B08-9D2D-406639D4C62BQ36897779-0ACB6B03-93C9-4563-9C46-6D3193B7B647Q36938143-2E91DC42-E735-4A81-9E95-924C3EE60483Q36979335-6CFEDAE5-1C13-4947-96E9-CFB06FCADC27Q37017056-EFF50601-3D3C-46F7-ADB9-4A4C047EC49AQ37093537-5F9F48E2-6674-4545-9021-1BA2BDFC1965Q37179400-0BCA9F9D-474F-4F7A-8299-341F5AF31E34Q37225176-B521104C-FAE2-40AF-A445-4A56A447FA34Q37595954-B65336D8-55FA-431A-92BF-C0D578FFD136Q37688671-B62F62CF-9FDD-4421-A52B-B899F0001B27Q37720438-52C24153-F4C5-4220-A945-7AF4F9E98395Q37770590-DC9748EF-A272-4257-8A07-01403E46ED59Q38067433-EA66601F-15E6-42ED-A1FF-53DB21563538Q38592167-023B5935-2A7B-4EE1-81A2-FE2574A3CCAFQ39958494-A32C0053-D60F-4FE3-926E-F70B70615CBBQ40035188-34193CF5-4804-4FF1-BFB2-7055BFFA19A6Q41470898-A12EE92B-614D-4FE3-9859-8F5C0E46C231Q47134293-2155E6B8-C605-4C1D-9D57-699643078BA4Q48163026-87190C74-690F-4805-92FF-803FF3E5A1E7Q51744236-B250BBFC-B595-4A0C-9577-2EA36127DF3CQ55115973-B5C07BAF-7886-4F5F-ABBB-F229CA40125EQ57644545-BD9A3A32-757E-463D-AE7B-AB62631B2AB1
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hereditary ovarian cancer.
@ast
Hereditary ovarian cancer.
@en
type
label
Hereditary ovarian cancer.
@ast
Hereditary ovarian cancer.
@en
prefLabel
Hereditary ovarian cancer.
@ast
Hereditary ovarian cancer.
@en
P3181
P1433
P1476
Hereditary ovarian cancer
@en
P2093
Adriana Ribé
Jaime Prat
P304
P3181
P356
10.1016/J.HUMPATH.2005.06.006
P407
P577
2005-08-01T00:00:00Z